574 related articles for article (PubMed ID: 15256108)
1. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].
Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108
[TBL] [Abstract][Full Text] [Related]
2. [The expression of A103 and inhibin alpha in adrenocortical adenoma by high-throughput tissue microarray techniques].
Zhang H; Liu W; Wang X; Li G; Guo J; Li F; Liao D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):424-6. PubMed ID: 12910679
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunomarkers for the identification of adrenocortical cells in cytology specimens.
Jalali M; Krishnamurthy S
Diagn Cytopathol; 2005 Aug; 33(2):78-82. PubMed ID: 16007649
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
Elmoneim HM; Samaka RM; Ali H
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854
[TBL] [Abstract][Full Text] [Related]
5. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
[TBL] [Abstract][Full Text] [Related]
6. Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas.
Jorda M; De MB; Nadji M
Appl Immunohistochem Mol Morphol; 2002 Mar; 10(1):67-70. PubMed ID: 11893039
[TBL] [Abstract][Full Text] [Related]
7. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.
Renshaw AA; Granter SR
Mod Pathol; 1998 Dec; 11(12):1160-4. PubMed ID: 9872645
[TBL] [Abstract][Full Text] [Related]
8. Expression of inhibin alpha in the human adrenal gland and adrenocortical tumors.
Arola J; Liu J; Heikkilä P; Voutilainen R; Kahri A
Endocr Res; 1998; 24(3-4):865-7. PubMed ID: 9888589
[TBL] [Abstract][Full Text] [Related]
9. A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases.
Loy TS; Phillips RW; Linder CL
Arch Pathol Lab Med; 2002 Feb; 126(2):170-2. PubMed ID: 11825112
[TBL] [Abstract][Full Text] [Related]
10. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
11. The expression of inhibin/activin subunits in the human adrenal cortex and its tumours.
Munro LM; Kennedy A; McNicol AM
J Endocrinol; 1999 May; 161(2):341-7. PubMed ID: 10320833
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunohistochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors.
Zhang H; Bu H; Chen H; Wei B; Liu W; Guo J; Li F; Liao D; Tang Y; Zhang Z
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):32-9. PubMed ID: 18091323
[TBL] [Abstract][Full Text] [Related]
13. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.
McCluggage WG; Burton J; Maxwell P; Sloan JM
J Clin Pathol; 1998 Feb; 51(2):114-6. PubMed ID: 9602683
[TBL] [Abstract][Full Text] [Related]
15. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
16. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of the monoclonal antibody A103 in fine-needle aspiration biopsies of the adrenal.
Shin SJ; Hoda RS; Ying L; DeLellis RA
Am J Clin Pathol; 2000 Feb; 113(2):295-302. PubMed ID: 10664633
[TBL] [Abstract][Full Text] [Related]
18. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
19. Melan-A (A103) and inhibin expression in ovarian neoplasms.
Yao DX; Soslow RA; Hedvat CV; Leitao M; Baergen RN
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):244-9. PubMed ID: 12966351
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of inhibin alpha-subunit in adrenal neoplasms.
Cho EY; Ahn GH
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):222-8. PubMed ID: 11556749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]